Castro, A.; Pittini, Á.; Berois, N.; Faccio, R.; Miranda, P.; Mombrú, Á.W.; Osinaga, E.; Pardo, H.
Development, Characterization, and Evaluation of Chi-Tn mAb-Functionalized DOTAP-PLGA Hybrid Nanoparticles Loaded with Docetaxel for Lung Cancer Therapy. Pharmaceutics 2025, 17, 164.
https://doi.org/10.3390/pharmaceutics17020164
AMA Style
Castro A, Pittini Á, Berois N, Faccio R, Miranda P, Mombrú ÁW, Osinaga E, Pardo H.
Development, Characterization, and Evaluation of Chi-Tn mAb-Functionalized DOTAP-PLGA Hybrid Nanoparticles Loaded with Docetaxel for Lung Cancer Therapy. Pharmaceutics. 2025; 17(2):164.
https://doi.org/10.3390/pharmaceutics17020164
Chicago/Turabian Style
Castro, Analía, Álvaro Pittini, Nora Berois, Ricardo Faccio, Pablo Miranda, Álvaro W. Mombrú, Eduardo Osinaga, and Helena Pardo.
2025. "Development, Characterization, and Evaluation of Chi-Tn mAb-Functionalized DOTAP-PLGA Hybrid Nanoparticles Loaded with Docetaxel for Lung Cancer Therapy" Pharmaceutics 17, no. 2: 164.
https://doi.org/10.3390/pharmaceutics17020164
APA Style
Castro, A., Pittini, Á., Berois, N., Faccio, R., Miranda, P., Mombrú, Á. W., Osinaga, E., & Pardo, H.
(2025). Development, Characterization, and Evaluation of Chi-Tn mAb-Functionalized DOTAP-PLGA Hybrid Nanoparticles Loaded with Docetaxel for Lung Cancer Therapy. Pharmaceutics, 17(2), 164.
https://doi.org/10.3390/pharmaceutics17020164